reports
FreightCar America, Inc. Announces Its 2026 Annual General Meeting and...
FreightCar America, Inc. Announces Its 2026 Annual General Meeting and Record Date CHICAGO, March 04, 2026 (GLOBE NEWSWIRE) -- FreightCar America, Inc. (NASDAQ: RAIL) (the “Company” or “FreightCar”) announced today that it will hold its annual general meeting of shareholders (the “AGM”) at 10:00 am (Central Time) on April 10, 2026. The AGM will be held in virtual format only, via live webcast on the Internet, with no physical, in-person meeting. The record date for determining shareholders entitled to notice of, and to vote at, the AGM will be the close of business on February 10, 2026. ...
Tanger Inc: 2 directors
Two Directors at Tanger Inc sold/sold after exercising options 20,432 shares at between 37.500USD and 37.610USD. The significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the comp...
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution ...
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share MIAMI, March 03, 2026 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) declares its monthly distribution for March 2026 of $0.1025 per share, payable on April 1, 2026 to stockholders of record as of March 16, 2026. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodic repo...
3D Systems Announces Date of Fourth Quarter and Full Year 2025 Financi...
3D Systems Announces Date of Fourth Quarter and Full Year 2025 Financial Results ROCK HILL, S.C., March 02, 2026 (GLOBE NEWSWIRE) -- (NYSE:DDD) announced today it will release its financial results for the fourth quarter and full year 2025 before the U.S. stock market opens on Monday, March 9, 2026. The company will hold a conference call and simultaneous webcast to discuss these financial results on Monday, March 9, 2026 at 8:30 a.m. Eastern Time. Fourth Quarter and Full Year 2025 Financial Results Conference CallDate: Monday, March 9, 2026Time: 8:30 a.m. Eastern TimeListen via webcast...
Concrete Pumping Holdings Sets First Quarter 2026 Earnings Conference ...
Concrete Pumping Holdings Sets First Quarter 2026 Earnings Conference Call for Tuesday, March 10, 2026 DENVER, March 02, 2026 (GLOBE NEWSWIRE) -- Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (“CPH” or the “Company”), a leading provider of concrete pumping and waste management services in the U.S. and U.K., will hold a conference call on Tuesday, March 10, 2026, at 5:00 p.m. Eastern Time to discuss its financial results for the first quarter ended January 31, 2026. The Company will report its financial results in a press release prior to the conference call. CPH’s CEO Bruce Young and CF...
OPKO Health to Participate in the Jefferies Biotech on the Beach Summi...
OPKO Health to Participate in the Jefferies Biotech on the Beach Summit MIAMI, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Biotech on the Beach Summit, being held March 10-11, 2026, at 1 Hotel South Beach in Miami. Management will be holding one-on-one meetings with investors registered for the event on Wednesday, March 11th. Investors interested in scheduling a meeting with OPKO management should contact their Jefferies representative. About OPKO Health OPKO is a multinational biopharmaceutic...
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financ...
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces financial guidance for the first quarter and full year 2026. Highlights from the fourth quarter of 2025 and recent weeks include the following: Entered into a research collaboration with Regeneron Pharmaceuticals to develop multispecific antibodies. This n...
PennantPark Floating Rate Capital Ltd. Prices Public Offering of $200 ...
PennantPark Floating Rate Capital Ltd. Prices Public Offering of $200 Million 6.75% Notes MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the “Company”) (NYSE: PFLT) today announced that it has priced an underwritten public offering of $200 million aggregate principal amount of its 6.75% notes due 2029 (the “Notes”). The Notes will mature on March 4, 2029 and may be redeemed in whole or in part at the Company’s option at any time at par plus a “make-whole” premium, if applicable, provided that the Notes may be redeemed at par three months prior to their ma...
OraSure Announces Fourth Quarter 2025 Financial Results
OraSure Announces Fourth Quarter 2025 Financial Results BETHLEHEM, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended December 31, 2025. “Our Q4 results were consistent with our expectations, and revenue of $26.8 million was above the midpoint of our guidance range,” said Carrie Eglinton Manner, President and CEO of OTI. “We supported our customers in navigating a challenging funding environment in 2025, and w...
PennantPark Floating Rate Capital Ltd. Completes the Reset of a $356.5...
PennantPark Floating Rate Capital Ltd. Completes the Reset of a $356.5 Million Securitization, Substantially Reducing Borrowing Costs MIAMI, Feb. 24, 2026 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the “Company”) (NYSE: PFLT) today announced that PennantPark CLO VIII, LLC, a wholly-owned and consolidated subsidiary of the Company, has closed the refinancing of a four-year reinvestment period, twelve-year final maturity $356.5 million debt securitization. The debt issued in this securitization (the “Debt”) is structured in the following manner: ClassPar Amount($ in millio...
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Avalo Therapeutics to Participate in Upcoming Investor Conferences WAYNE, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced that management will participate in the following investor conferences: TD Cowen Annual Healthcare ConferenceFireside Chat March 3, 2026, at 9:50 am ET Leerink Partners Global Healthcare ConferenceFireside ChatMarch 10, 2026, at 4:20 pm ET Live webcasts and replays, when available, can ...
FreightCar America, Inc. To Release Fourth Quarter and Full Year 2025 ...
FreightCar America, Inc. To Release Fourth Quarter and Full Year 2025 Results On March 9, 2026 CHICAGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- FreightCar America, Inc. (NASDAQ: RAIL), a diversified manufacturer of railroad freight cars, today announced that it will release its fourth quarter and full year 2025 financial results on Monday, March 9, 2026, after the market close, and host a teleconference to discuss its fourth quarter and full year 2025 results on the following day. Teleconference details are as follows: March 10, 202611:00 a.m. Eastern TimePhone: 1-877-407-0789 or 1-201-689-856...
Annaly Capital Management Inc: 3 directors
Three Directors at Annaly Capital Management Inc sold/sold after exercising options 94,761 shares at between 23.120USD and 23.140USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary t...
Avalo Therapeutics Announces Inducement Grants to New Employees Under ...
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) WAYNE, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced the grant of inducement equity awards to two new employees. The Compensation Committee of the Board of Directors of Avalo approved the grants of nonstatutory stock options to purchase an aggregate of 82,000 shares of common stock (the “Options”) as inducem...
3D Systems Expands NextDent® Jetted Denture Solution with Three New Ba...
3D Systems Expands NextDent® Jetted Denture Solution with Three New Base Shades to Enhance Aesthetics, Production Flexibility, and Patient Satisfaction Adds three new denture base shades (DP, LP, RP) to better match diverse natural gum tones and address real patient diversityExpands production flexibility for dental laboratoriesReinforces market leadership in monolithic, multi-material denture printingDelivers up to 300% faster production, over 50% less manual labor, and one-day turnaround (vs. five days traditional) — slashing labor, streamlining workflows, and cutting costs for labs ROCK...
OPKO Health to Report Fourth Quarter 2025 Financial Results on Februar...
OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 MIAMI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on Thursday, February 26, 2026. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participants to pre-r...
OraSure to Launch OraQuick™ HIV Self-Test in Canada
OraSure to Launch OraQuick™ HIV Self-Test in Canada BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its OraQuick™ HIV Self-Test has received a license from Health Canada for use in Canada. The OraQuick™ HIV Self-Test is a point-of-care rapid antibody test. It is Canada’s first oral HIV self-test and detects antibodies for both HIV-1 and HIV-2, enabling individuals to find out their HIV status with a simple oral swab in as little as ...
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Ear...
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th BETHLEHEM, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2025 financial results and certain business developments for 5 p.m. ET on February 25, 2026. A webcast of the conference call will be available on the investor relations page of OraSure’s website at . Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The w...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.